{
    "nct_id": "NCT03904199",
    "official_title": "A Prospective Randomized Study of a Personalized Approach to the Inpatient Management of Hospitalized Oncology Patients With Hyperglycemia",
    "inclusion_criteria": "* Provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* Provide race and ethnicity information\n* Male or female, aged 18 years or greater\n* Diagnosed with cancer\n* Hospitalized at MCC in the medical, hematologic, or bone marrow transplant units\n* Having in-hospital hyperglycemia with or without a pre-existing diagnosis of DM, with 2 measurements of BG > 180 mg/dL and/or 1 measurement of BG > 350mg/dL within the first 72 hours of admission, detected by bedside point-of-care testing and/or basic metabolic panel laboratory data.\n* Participants enrolled in other clinical trials are admissible to this trial.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* An individual who meets any of the following criteria will be excluded from participation in this study:\n* Participants < 18 years of age\n* Participants at the end of life and/or with limited life expectancies (< 6 months)\n* Participants without cancer diagnoses\n* Surgical patients and patients admitted directly to the intensive care unit, other than those in the Bone Marrow Transplant Unit, who are included\n* Participants treated and discharged in outpatient settings (ie, direct referral center, infusion center, or clinical research unit) or those admitted for observation only (hospitalized less than 24 hours)\n* Participants on total parenteral nutrition\n* Participants on insulin pumps\n* Participants admitted with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome\n* Pregnant Participants based on medical history\n* Participants being followed by endocrinology for hyperglycemia or hypoglycemia",
    "miscellaneous_criteria": ""
}